Potential Advantages of Charting with the Creighton Model FertilityCare System in Pregnancy 

Teresa Hilgers MD, MS, CFCMC, FCP OB/GYN Physician at the Saint Paul VI Institute University D & E 

Objectives: 

• Identify details of the Creighton Model chart specific to pregnancy 
• Describe potential abnormal biomarkers that should be addressed in pregnancy to prevent abnormal outcomes 
• Explain the benefits of instructing clients to chart throughout their pregnancies 

This audio download is from the 44th Annual Meeting of the American Academy of FertilityCare Professionals. The PowerPoint associated with this presentation is available in the file library of the member portal.